header image

Vienna, Austria

History:

The Vienna plant was the first Octapharma-owned production site. The premises were acquired in 1989 from the state-owned Heilmittelwerke Austria/Chemie Linz. The site was the first to manufacture a solvent detergent (S/D) treated FVIII preparation and later first virus-inactivated plasma for transfusion. The size of the premises has nearly tripled to 80,000 m², the original buildings have been upgraded, equipment has been installed with the latest in production and laboratory technology and new buildings have been constructed. The plant‘s annual fractionation capacity has grown to 1.4 Mio Liter Plasma. In the beginning, there were 80 staff, the plant now employs more than 1,100 people (2018). Recent projects include a new Research & Development building and the establishment of a Pilot Plant.

 

The new Research & Development building, which will be opened in autumn 2018, includes six floors and 4,500 m² floor space for about 100 employees. The construction of the Pilot Plant will be finished in autumn 2018. This production line links R&D and routine production.  With these recent investments, the entire production sequence is present in Vienna: from research in a small production scale to the Pilot Plant with a medium production scale up to routine production.

In order to meet the challenges of safe and economical fractionation, tremendous efforts have gone into implementing and continuously upgrading the site's Quality Systems. The plant itself and its Quality Systems are subject to regular audits by authorities from all over the world. In 2004 the plant was FDA-licensed and currently manufactures four products for the US market.

 

On-site units


Fractionation/purification; pharmaceutical production; labelling, packaging and storage facilities; Quality Control; R&D laboratories; administrative units; Clinical Research & Development Unit; International Drug Regulatory Affairs; Corporate Supply Chain; Corporate Quality and Corporate Production departments
 
On-site subsidiaries

Octapharma Pharmazeutika Produktionsges.m.b.H. (Operations)
Octapharma Handelsgesellschaft m.b.H. (Marketing & Sales)

 

 

Austria’s Top Employers 2018 for the chemical and pharma industry from Trend magazine